Leukoplakia: Molecular understanding of pre-malignant lesions and implications for clinical management

Molecular Medicine Today

Volumn 3, Issue 10, 1997, Pages 442-448

  Mao, Li ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIBODY; CARCINOGEN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; FENRETINIDE; ISOTRETINOIN; MESSENGER RNA; ONCOPROTEIN; PROTEIN P53; RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR; RETINOL; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CHEMOPROPHYLAXIS; CHROMOSOME ABERRATION; CLINICAL TRIAL; DNA DAMAGE; DNA PROBE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEUKOPLAKIA; MOUTH CANCER; POLYMERASE CHAIN REACTION; PRECANCER; PROTO ONCOGENE; REVIEW; TOBACCO; TUMOR SUPPRESSOR GENE; VIRUS INFECTION;

EID: 85041094785     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(97)01111-8     Document Type: Review

References (54)

1. Hunter, T. (1991) Cooperation between oncogenes, Cell 64, 249-270
2. Kinzler, K.E. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer, Cell 87, 159-170
3. Bishop, J.M. (1991) Molecular themes in oncogenesis, Cell 64, 235-248
4. Vogelstein, B. et al. (1992) Genetic alteration during colorectal tumor development, New Engl. J. Med. 319, 525-532
5. Papadimitrakopoulou, V.A. et al. (1997) Low-dose isotretinoin versus β-carotene to prevent oral carcinogenesis: long-term follow-up, J. Natl. Cancer Inst. 89, 257-258
6. Cawson, R.A., Langdon, J.D. and Eveson, J.W. (1996) White, red and pigmented lesions of the oral mucosa, in Surgical Pathology of the Mouth and Jaws, pp. 166-189, Wright
7. Bánóczy, J. (1982) The role of etiological factors, in Oral Leucoplakia (Bánóczy, J., ed.), pp. 28-53, Martinus Nijhoff
8. Silverman, S., Jr, Gorsky, M. and Lozada, F. (1984) Oral leukoplakia and malignant transformation: A follow-up study of 257 patients, Cancer 53, 563-568
9. Lumerman, H., Freedman, P. and Kerpel, S. (1995) Oral epithelial dysplasia and the development of invasive squamous cell carcinoma, Oral Surg. Oral Med. Oral Pathol. 79, 321-329
10. Slaughter, D.P., Southwick, H.W. and Smejkal, W. (1953) Field cancellation in oral stratified squamous epithelium: clinical implications of multicentric origin, Cancer 6, 963-968
11. Cooper, J.S. et al. (1989) Second malignancies in patients who have head and neck cancers: incidence, effect on survival and implications for chemoprevention based on the RTOG experience, Int. J. Radiat. Oncol. Biol. Phys. 17, 449-456
12. Licciardello, J.T., Spitx, M.R. and Hong, W.K. (1989) Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus and lung, Int. J. Radiat. Oncol. Biol. Phys. 17, 467-476
13. Auerbach, O. et al. (1961) Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer, New Engl. J. Med. 265, 253-267
14. Lee, J.S. et al. (1993) Detection of chromosome polysomy in oral leukoplakia, a pre-malignant lesion, J. Natl. Cancer Inst. 85, 1951-1954
15. Califano, J. et al. (1996) Genetic progression model for head and neck cancer: implications for field cancerization, Cancer Res. 56, 2488-2493
16. Bedi, G.C. et al. (1996) Multiple head and neck tumors: evidence for a common clonal origin, Cancer Res. 56, 2484-2487
17. Carey, T.E. (1996) Field cancerization: are multiple primary cancers monoclonal or polyclonal? Ann. Med. 28, 183-188
18. Moon, R.C., Mdhta, R.G. and Rao, K.V. (1994) Retinoids and cancer in experimental animals, in The Retinoids (2nd edn) (Sporn, M.B., Roberts, A.B. and Goodman, D. S., eds), pp. 573-586, Raven
19. Lippman, S.M., Spitz, M.R., Huber, M. and Hong, W.K. (1995) Strategies for chemo-prevention study of pre-malignant lesions and second primary tumors in the head and neck, Curr. Opin. Oncol. 7, 234-240
20. Hong, W.K. et al. (1986) 13-cis-retinoic acid in the treatment of oral leukoplakia, New Engl. J. Med. 153, 1501-1505
21. Lippman, S.M. et al. (1993) Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis, New Engl. J. Med. 328, 15-20
22. De Palo, G. et al. (1995) Controlled clinical trials with fentetinide in breast cancer, basal cell carcinoma and oral leukoplakia, J. Cell. Biochem. 22, (Suppl.), 11-17
23. Tradati, N. et al. (1994) Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR), Cancer Lett. 76, 109-111
24. Arnoldus, E.P. et al. (1991) Feasibility of in situ hybridization with chromosome specific DNA probes on paraffin wax embedded tissue, J. Clin. Pathol. 44, 900-904
25. Brennan, J.A. et al. (1995) Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck, New Engl. J. Med. 332, 712-717
26. Cairns, P. et al. (1995) High frequency of homozygous deletion at p16/CDKN2 in primary human tumors, Nat. Genet. 11, 210-212
27. Andre, L. et al. (1996) High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma, Cancer Res. 56, 3630-3633
28. Nawroz, H. et al. (1994) Allelotype of head and neck squamous cell carcinoma, Cancer Res. 54, 1152-1155
29. El-Naggar, A.K. et al. (1995) Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma, Cancer Res. 55, 2656-2659
30. Jones, J.W. et al. (1997) Frequent loss of heterozygosity on chromosome arm 18q in squamous cell carcinomas, Arch. Otolaryngol. Head Neck Surg. 123, 610-614
31. Renan, M.J. (1993) How many mutations are required for tumorigenesis? Implications from human cancer data, Mol. Carcinog. 7, 139-146
32. Shay, J.W. and Bacchetti, S. (1997) A survey of telomerase activity in human cancer, Eur. J. Can. 33, 787-791
33. Mao, L. et al. (1996) Telomerase activity in the pathogenesis of head and neck squamous cell carcinoma, Cancer Res. 56, 5600-5604
34. Harris, C.C. and Hollstein, M. (1993) Clinical implications of the p53 tumor-suppressor gene, New Engl. J. Med. 329, 1318-1327
35. Greenblatt, M.S. et al. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis, Cancer Res. 54, 4855-4878
36. Shintani, S. et al. (1995) Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinoma, Anticancer Res. 15, 305-308
37. Lippman, S.M. et al. (1995) p53 and retinoid chemoprevention of oral carcinogenesis, Cancer Res. 55, 16-19
38. Shin, D.M. et al. (1997) Accumulation of p53 protein and retinoic acid receptor β in retinoid chemoprevention, Clin. Cancer Res. 3, 875-880
39. Kropveld, A., van Mansfeld, A.D.M., Nabben, N., Jordijk, G.J. and Slootweg, P.J. (1996) Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients, Oral Oncol., Eur. J. Cancer 6, 388-393
40. Bradford, C.R. et al. (1997) p53 mutation as a prognostic marker in advanced laryngeal carcinoma, Arch. Otolaryngol. Head Neck Surg. 123, 605-609
41. Ko, L.J. and Prives, C. (1996) p53: puzzle and paradigm, Genes Dev. 10, 1054-1072
42. Neilsen, H. et al. (1996) Human papillomavirus in oral pre-malignant lesions, Eur. J. Cancer 32B, 264-270
43. Hubbert, N.L., Sedman, S.A. and Schiller, J.T. (1992) Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes, J. Virol. 66, 6237-6241
44. Lotan, R. et al. (1995) Expression of retinoic acid receptor-β in pre-malignant oral lesions and its up-regulation by isotretinoin, New Engl. J. Med. 332, 1405-141
45. Mao, L. et al. (1996) Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment, Nat. Med. 2, 682-685
46. INK4ain oral premalignant lesions, Oncogene 14, 1799-1803
47. Emilion, G., Langdon, J.D., Speight, P. and Partridge, M. (1996) Frequent gene deletions in potentially malignant oral lesions, Br. J. Cancer 73, 809-813
48. Allsopp, R.C. et al. (1992) Telomere length predicts replicative capacity of human fibroblasts, Proc. Natl. Acad. Sci. U. S. A. 89, 10114-10118
49. Morin, G.B. (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats, Cell 59, 521-529
50. Kim, N.W. et al. (1994) Specific association of human telomerase activity with immortal cells and cancer, Science 266, 2011-2015
51. Mutirangura, A. et al. (1996) Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma, Cancer Res. 56, 3530-3533
52. van Steensel, B. and de Lange, T. (1997) Control of telomere length by the human telomeric protein TRF1, Nature 385, 740-743
53. Shalon, D., Smith, S.J. and Brown, P.O. (1996) A DNA microarray system for analysing complex DNA samples using two-color fluorescent probe hybridization, Genome Res. 6, 639-645
54. Schena, D. et al. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray, Science 270, 467-473